Sara Luis-Fernandez

Santander, CB, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Burden and Impact of Infectious Complications After Allogeneic Hematopoietic Cell Transplantation in Older Patients: A GETH-TC Study.

Burden and Impact of Infectious Complications After Allogeneic Hematopoietic Cell Transplantation in Older Patients: A GETH-TC Study.

Journal: Transplantation and cellular therapy

Published: June 03, 2026

Feasibility and Interim Safety and Efficacy Analysis of a Fast Automated Production of Prophylactic Cytomegalovirus-Specific Cytotoxic T Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation.

Feasibility and Interim Safety and Efficacy Analysis of a Fast Automated Production of Prophylactic Cytomegalovirus-Specific Cytotoxic T Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation.

Journal: Transplantation and cellular therapy

Published: May 30, 2026

Real-world effectiveness and safety of Zanubrutinib in Spanish patients with relapsed/refractory marginal zone lymphoma.

Real-world effectiveness and safety of Zanubrutinib in Spanish patients with relapsed/refractory marginal zone lymphoma.

Journal: Blood advances

Published: March 23, 2026

Prospective implementation of the HCT frailty scale in adults with lymphoproliferative syndromes candidates for autologous haematopoietic stem cell transplantation: Results from a multicentre GETH-TC study.

Prospective implementation of the HCT frailty scale in adults with lymphoproliferative syndromes candidates for autologous haematopoietic stem cell transplantation: Results from a multicentre GETH-TC study.

Journal: British journal of haematology

Published: February 24, 2026

Real-World Validation of the Transplant Conditioning Intensity (TCI) Score in Allogeneic Hematopoietic Cell Transplantation: A Spanish Multicenter Study on behalf of GETH-TC.

Real-World Validation of the Transplant Conditioning Intensity (TCI) Score in Allogeneic Hematopoietic Cell Transplantation: A Spanish Multicenter Study on behalf of GETH-TC.

Journal: Transplantation and cellular therapy

Published: December 27, 2025

Donor age as an independent predictor of inferior outcomes after haploidentical hematopoietic cell transplantation in acute myeloid leukemia. Study conducted on behalf of GETH-TC.

Donor age as an independent predictor of inferior outcomes after haploidentical hematopoietic cell transplantation in acute myeloid leukemia. Study conducted on behalf of GETH-TC.

Journal: Frontiers in immunology

Published: September 06, 2025

Safety of Post-Transplant Cyclophosphamide-Based Prophylaxis in AML Patients with Pre-Existing Cardiac Morbidity Undergoing Allogeneic Hematopoietic Cell Transplantation.

Safety of Post-Transplant Cyclophosphamide-Based Prophylaxis in AML Patients with Pre-Existing Cardiac Morbidity Undergoing Allogeneic Hematopoietic Cell Transplantation.

Journal: Cancers

Published: August 20, 2025

Changes in the bacterial profile and diversity of the gut microbiota in allogeneic hematopoietic stem cell transplant recipients.

Changes in the bacterial profile and diversity of the gut microbiota in allogeneic hematopoietic stem cell transplant recipients.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: August 14, 2025

Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients: The Experience of the Grupo Español de Trasplante Hematopoyético y Terapia Celular.

Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients: The Experience of the Grupo Español de Trasplante Hematopoyético y Terapia Celular.

Journal: Transplantation

Published: June 17, 2025

Fixed Low-Dose ATLG in HLA-Matched Transplantation is Safe and Effective.

Fixed Low-Dose ATLG in HLA-Matched Transplantation is Safe and Effective.

Journal: Transplantation and cellular therapy

Published: May 08, 2025

Frailty dynamics and their impact on QoL in patients undergoing autologous HCT for multiple myeloma: Results from a multicentre GETH-TC study.

Frailty dynamics and their impact on QoL in patients undergoing autologous HCT for multiple myeloma: Results from a multicentre GETH-TC study.

Journal: British journal of haematology

Published: May 06, 2025

Inhibition of NEDDylation enhances the cytostatic effect of Rohinitib on chronic lymphocytic leukemia cells.

Inhibition of NEDDylation enhances the cytostatic effect of Rohinitib on chronic lymphocytic leukemia cells.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 02, 2025

Showing 1-12 of 23

Last Updated: 09/26/2026